Sells medical imaging equipment and pharmaceutical diagnostics, along with AI and software solutions, to healthcare providers, researchers, and public and government institutions.
10-K for FY2025, filed Feb 4, 2026We generate revenue from the sale of medical devices, consumable products, service capabilities, and AI-enabled cloud and software…View ↗
Our Imaging segment includes five product lines and associated service capabilities: Molecular Imaging (“MI”), Computed Tomography (“CT”)…View ↗
Our PDx segment supplies contrast and radiopharmaceutical imaging agents to the global radiology and nuclear medicine industries. These…View ↗
Customers buy equipment, imaging agents, software offerings and upgrades, generally billed around delivery and acceptance; they also buy maintenance, repairs, training and warranties, including coverage provided over a contract term.
10-K for FY2025, filed Feb 4, 2026Our revenues primarily consist of sales of products and services to customers. Products include equipment, imaging agents, software-related…View ↗
We primarily recognize revenue from sales of products at the point in time that the customer obtains control, which is generally no earlier…View ↗
For standard, assurance-type warranties that are provided with products, we estimate the cost that may be incurred during the warranty…View ↗
10-K for FY2025, filed Feb 4, 2026
FY2025 revenue by product or service ↗$20.6B
10-K for FY2025, filed Feb 4, 2026
$20.6B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2025, filed Feb 4, 2026 |
66%
FY2022: 66%
|
Product, FY2025
$13.7B Sources
|
Sold outright |
|
Service
Recurring
10-K for FY2025, filed Feb 4, 2026 |
34%
FY2022: 34%
|
Service, FY2025
$7B Sources
|
Recurring |
Hospitals and health systems, researchers, and public, private, academic, and government institutions are customers; the company sells through direct teams and third-party partners, including agents and distributors.
10-K for FY2025, filed Feb 4, 2026
Yes. It kept 10 cents of every revenue dollar as net income in FY2025.
10-Q for Q3 FY2026, filed Oct 28, 2026
Open tableView ↗
8-K, filed Aug 18, 2026
CHICAGO — August 18, 2026 — GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today announced the appointment of…View ↗
8-K, filed Jul 29, 2026
Organic revenue growth* of 3.0% to 4.0% year-over-year Adjusted EBIT margin* of 15.4% to 15.7%, reflecting an expansion of 10 bps to 40 bps…View ↗
Reorganized imaging businesses
The older report presents Ultrasound as its own business and places image-guided therapies in Imaging; the latest report groups specialized ultrasound and procedural guidance within Advanced Visualization Solutions.
10-K for FY2022, filed Feb 15, 2023
Competes with Siemens Healthineers, Philips Healthcare, United Imaging, Mindray, Canon, Bayer, Bracco, Guerbet, and Curium
10-K for FY2025, filed Feb 4, 2026The global medical technology industry is highly competitive and includes global and regional participants of all sizes that can vary by…View ↗
Loading...